← FDA Drug Approvals (Drugs@FDA)
SUNITINIB MALATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NATCO PHARMA · Approved 2023-10-24
Drug application
- FDA Application #
ANDA218024- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- SUNITINIB MALATE
- Generic name
- Sunitinib Malate
- Active ingredients
- SUNITINIB MALATE
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- NATCO PHARMA
- First approval
- 2023-10-24
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown